Discovery through
Commercialization
The 7th Annual
Conference will include multiple tracks focusing upon the confluence of
discovery, development, manufacturing and commercialization
towards the development of innovative, path-breaking strategies in the
realm of personalised health care.
Here are a few of the sessions at
this year's conference.
Target Discovery
This session chaired by V. N.
Balaji, Consultant, Discovery Research will discuss
- Applications
of Next Generation Sequencing and Genomics—from Target Discovery
to Clinical Trials and Beyond by
Raja Mugasimangalam, CEO, Genotypic Technology
- Distilling
Omics Data for Drug Discovery by
Kalpana Krishnaswamy, CEO, Metaome Science Informatics
- Homology
Modeling of Proteins and Ligand Docking: How close are we to drug
discovery?
by R.
Sowdhamini, Associate Professor, National Centre for Biological
Sciences Processes
Public Knowledge and Perceptions as
Drivers or Barriers to the
Future of Clinical Research in India
This session chaired by Tal Burt,
Scientific Director, Duke Global Proof-of-Concept (POC), Research
Network will discuss
- PARTAKE
Program and Survey of Public Knowledge and Perceptions of Clinical
Research
by Tal Burt,
Scientific Director, Duke Global Proof-of-Concept (POC) Research
Network
- Challenges
of Drug Development in India – The Relevance of Public Awareness
and Partnership
by Krathish
Bopanna, President and CEO, Semler Research
- The
Role of Stakeholder Collaborations in the Ethical Conduct of
Clinical Research
by Nandini
Kumar, Former Deputy Director General, Senior Grade Investigator
NIH project, National Institute of Epidemiology
Health Economics and Valuation
This session chaired by Shashidhar
Rao, Head Global Medical Affairs and HEOR, India Operations, Novartis
Healthcare will discuss
- New
Molecules: Paths to their Development and Commercialization in
India by Nidhi
Saxena, Founder and CEO, Karmic Lifesciences
- Personalization
and Regulatory Framework by
Arun Bhatt, President, Clininvent Research
- Approach
to Early Phase Health Economics Evaluations by Adrian McKemey,
Practice Leader, Product Development & Commercialization,
Quintiles
7th Annual
Conference Registration Fees Reduced
Registration fees at the 7th Annual
Conference have been reduced by nearly 20% to as low as Rs. 9,000 +
taxes to help the industry participate in large numbers and gain
immensely through this unique networking opportunity. Click here
to view the conference program with over 75 International &
India industry leaders.
Follow us and tweet on the 7th
Annual Conference with #DIAIndiaAM2012
|
No comments:
Post a Comment